Fidelity Investments’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$134K Buy
190,126
+45,740
+32% +$42.7K ﹤0.01% 3677
2025
Q4
$224K Buy
144,386
+10,450
+8% +$16.7K ﹤0.01% 3387
2025
Q3
$212K Sell
133,936
-1,801,245
-93% -$3.13M ﹤0.01% 3320
2025
Q2
$4.22M Sell
1,935,181
-1,009,789
-34% -$2.45M ﹤0.01% 2224
2025
Q1
$8.04M Sell
2,944,970
-191,801
-6% -$756K ﹤0.01% 1999
2024
Q4
$13M Buy
3,136,771
+154,222
+5% +$583K ﹤0.01% 1862
2024
Q3
$11.6M Sell
2,982,549
-437,232
-13% -$1.84M ﹤0.01% 1874
2024
Q2
$13.4M Sell
3,419,781
-28,870
-0.8% -$124K ﹤0.01% 1785
2024
Q1
$14.4M Buy
3,448,651
+614,936
+22% +$2.89M ﹤0.01% 1769
2023
Q4
$13.3M Buy
2,833,715
+2,831,312
+117,824% +$11M ﹤0.01% 1755
2023
Q3
$7.5K Buy
2,403
+1,022
+74% +$4.11K ﹤0.01% 4217
2023
Q2
$6.34K Sell
1,381
-1,160
-46% -$5.33K ﹤0.01% 4291
2023
Q1
$12.6K Sell
2,541
-2,399
-49% -$11.8K ﹤0.01% 4040
2022
Q4
$27K Sell
4,940
-59,704
-92% -$366K ﹤0.01% 3665
2022
Q3
$420K Buy
64,644
+2,116
+3% +$11.8K ﹤0.01% 2831
2022
Q2
$296K Buy
62,528
+1,983
+3% +$9.77K ﹤0.01% 3016
2022
Q1
$423K Buy
+60,545
New +$413K ﹤0.01% 3038

Other funds holding MXCT

Fidelity Investments's MXCT Position: Q1 2026 in Review

Fidelity Investments increased its MaxCyte (MXCT) stake by 32% in Q1 2026, buying an estimated $42.7K and bringing the position to 190,126 shares worth $134K. The position accounts for ﹤0.01% of the portfolio, ranked #3677.

Fidelity Investments first reported a position in MXCT in Q1 2022 and has held it in 17 quarters since. The position peaked at $14.4M in Q1 2024. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • Fidelity Investments held 190,126 shares of MaxCyte worth $134K as of Q1 2026.
  • Fidelity Investments bought 45,740 MaxCyte shares in Q1 2026, an estimated $42.7K.
  • MaxCyte made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #3677 holding.
  • Fidelity Investments first reported a position in MaxCyte in Q1 2022 and has held it in 17 quarters since.
  • Fidelity Investments's MaxCyte position peaked at $14.4M in Q1 2024.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.